Yale OCD Research Clinic

Home | Studies | Contact | Directions | Resources | Personnel | Publications

PUBLICATIONS

Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder.

Riluzole augmentation for treatment-resistant obsessive-compulsive disorder: an open-label trial.

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder.

Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder

A systematic review: antipsychotic augmentation with treatment-refractory obsessive-compulsive disorder.

Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors.

Systematic review: pharmacological and behavioral treatment for trichotillomania.

Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review.

Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of thirteen cases, with long-term follow-up. In press, Journal of Clinical Psychopharmacology.

Riluzole in the treatment of mood and anxiety disorders. In press, CNS Drugs.

Home | Studies | Contact | Directions | Resources | Personnel | Publications

Copyright ©2005. Yale University School of Medicine, Psychiatry Department. All rights reserved.
Comments or suggestions to the site editor.

Home URL: http://info.med.yale.edu/ysm